Moreover, correlation analysis showed a moderate positive correlation of PRMT1 and c-Fos expression in GC samples compared to NATs (R = 0.36) (Fig. 8I), suggesting that PRMT1 appears to have a synergistic effect on c-Fos expression in patients with GC. The gene discussed is FOS; the disease is gastric cancer.